Procavea Biotech AG

Procavea Biotech is on a mission to revolutionize the delivery of RNA therapeutics and small molecule drugs. We will bring a first-in-class protein-based delivery platform for oligonucleotides and small molecules to the market. The technology was developed by us at ETHZ and is protected in two patents. Our current focus is on the Antisense and RNAi Therapeutics market, where there is great need for innovative delivery solutions. Our target customers are pharmaceutical companies who will gain a competitive advantage by using our unique technology. Through strategic partnerships we will license out bespoke delivery systems at various stages of development to meet our customers' needs. Long term we aim to develop our own therapeutic pipeline.